AU2003216501A8 - Methods of treating pin1 associated disorders - Google Patents
Methods of treating pin1 associated disordersInfo
- Publication number
- AU2003216501A8 AU2003216501A8 AU2003216501A AU2003216501A AU2003216501A8 AU 2003216501 A8 AU2003216501 A8 AU 2003216501A8 AU 2003216501 A AU2003216501 A AU 2003216501A AU 2003216501 A AU2003216501 A AU 2003216501A AU 2003216501 A8 AU2003216501 A8 AU 2003216501A8
- Authority
- AU
- Australia
- Prior art keywords
- treating
- methods
- associated disorders
- pin1 associated
- pin1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
- A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36079902P | 2002-03-01 | 2002-03-01 | |
US60/360,799 | 2002-03-01 | ||
PCT/US2003/006518 WO2003074002A2 (en) | 2002-03-01 | 2003-03-03 | Methods of treating pin1 associated disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003216501A1 AU2003216501A1 (en) | 2003-09-16 |
AU2003216501A8 true AU2003216501A8 (en) | 2003-09-16 |
Family
ID=27789027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003216501A Abandoned AU2003216501A1 (en) | 2002-03-01 | 2003-03-03 | Methods of treating pin1 associated disorders |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003216501A1 (en) |
WO (1) | WO2003074002A2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5972697A (en) * | 1995-11-13 | 1999-10-26 | The Salk Institute For Biological Studies | NIMA interacting proteins |
-
2003
- 2003-03-03 AU AU2003216501A patent/AU2003216501A1/en not_active Abandoned
- 2003-03-03 WO PCT/US2003/006518 patent/WO2003074002A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003216501A1 (en) | 2003-09-16 |
WO2003074002A3 (en) | 2003-12-04 |
WO2003074002A2 (en) | 2003-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL208191A0 (en) | Compositions and methods for treating rage-associated disorders | |
AU2003239489A8 (en) | Method of treating dyslipidemic disorders | |
AU2003286567A8 (en) | Methods for the treatment of skin disorders | |
PL372425A1 (en) | Dihydrobenzodiazepin-2-one-derivatives for the treatment of neurological disorders | |
PL373002A1 (en) | Methods of treating ileus | |
IL164352A0 (en) | Methods for treating tweak-related conditions | |
HK1203216A1 (en) | Materials and methods for treating disorders of the ear | |
EP1476147A4 (en) | Methods for treating eye disorders | |
EP1567198A4 (en) | Materials and methods for treating ocular-related disorders | |
AU2003270536A1 (en) | Method of treating skin disorders | |
IL163993A0 (en) | Method for treating cognitive disorders | |
IL162053A0 (en) | Method for the treatment of bone disorders | |
GB0208897D0 (en) | New method of treatment | |
GB0217493D0 (en) | Novel methods of treatment | |
AU2003216501A8 (en) | Methods of treating pin1 associated disorders | |
EP1425020A4 (en) | Methods and compositions for treating apoptosis associated disorders | |
GB0221712D0 (en) | Methods of treatment | |
AU2003202255A8 (en) | Compositions for treatment of central nervous system neoplasms, and methods of making and using the same | |
AU2003297259A8 (en) | Methods and compositions for treating neurological disorders | |
IL161630A0 (en) | Methods of treating endometreosis | |
GB0216097D0 (en) | Treatment of proliferative disorders | |
AU2003228813A8 (en) | Methods for treating neuronal disorders | |
GB0213198D0 (en) | Method of treatment | |
IL142102A0 (en) | Zinc-sensing receptor and methods of treatment of disorders associated herewith | |
GB0207091D0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |